Your browser doesn't support javascript.
Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong Kong.
Cheng, Vincent Chi-Chung; Siu, Gilman Kit-Hang; Wong, Shuk-Ching; Au, Albert Ka-Wing; Ng, Cecilia Suk-Fun; Chen, Hong; Li, Xin; Lee, Lam-Kwong; Leung, Jake Siu-Lun; Lu, Kelvin Keru; Lo, Hazel Wing-Hei; Wong, Evelyn Yin-Kwan; Luk, Shik; Lam, Bosco Hoi-Shiu; To, Wing-Kin; Lee, Rodney Allan; Lung, David Christopher; Kwan, Mike Yat-Wah; Tse, Herman; Chuang, Shuk-Kwan; To, Kelvin Kai-Wang; Yuen, Kwok-Yung.
  • Cheng VC; Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
  • Siu GK; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Wong SC; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Au AK; Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hong Kong Special Administrative Region, China.
  • Ng CS; Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
  • Chen H; Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
  • Li X; Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
  • Lee LK; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Leung JS; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Lu KK; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Lo HW; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Wong EY; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Luk S; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
  • Lam BH; Department of Pathology, Princess Margaret Hospital, Hong Kong Special Administrative Region, China.
  • To WK; Department of Pathology, Princess Margaret Hospital, Hong Kong Special Administrative Region, China.
  • Lee RA; Department of Pathology, Princess Margaret Hospital, Hong Kong Special Administrative Region, China.
  • Lung DC; Department of Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong Special Administrative Region, China.
  • Kwan MY; Department of Pathology, Hong Kong Children's Hospital / Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
  • Tse H; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region, China.
  • Chuang SK; Department of Pathology, Hong Kong Children's Hospital, Hong Kong Special Administrative Region, China.
  • To KK; Centre for Health Protection, Department of Health, Hong Kong Special Administrative Region, China.
  • Yuen KY; Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Lancet Reg Health West Pac ; 17: 100281, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1446927
ABSTRACT

BACKGROUND:

Global dissemination of SARS-CoV-2 Variants of Concern (VOCs) remains a concern. The aim of this study is to describe how mass testing and phylogenetic analysis successfully prevented local transmission of SARS-CoV-2 VOC in a densely populated city with low herd immunity for COVID-19.

METHODS:

In this descriptive study, we conducted contact tracing, quarantine, and mass testing of the potentially exposed contacts with the index case. Epidemiological investigation and phylogeographic analysis were performed.

FINDINGS:

Among 11,818 laboratory confirmed cases of COVID-19 diagnosed till 13th May 2021 in Hong Kong, SARS-CoV-2 VOCs were found in 271 (2.3%) cases. Except for 10 locally acquired secondary cases, all SARS-CoV-2 VOCs were imported or acquired in quarantine hotels. The index case of this SARS-CoV-2 VOC B.1.351 epidemic, an inbound traveler with asymptomatic infection, was diagnosed 9 days after completing 21 days of quarantine. Contact tracing of 163 contacts in household, hotel, and residential building only revealed 1 (0.6%) secondary case. A symptomatic foreign domestic helper (FDH) without apparent epidemiological link but infected by virus with identical genome sequence was subsequently confirmed. Mass testing of 0.34 million FDHs identified two more cases which were phylogenetically linked. A total of 10 secondary cases were identified that were related to two household gatherings. The clinical attack rate of household close contact was significantly higher than non-household exposure during quarantine (7/25, 28% vs 0/2051, 0%; p<0.001).

INTERPRETATION:

The rising epidemic of SARS-CoV-2 VOC transmission could be successfully controlled by contact tracing, quarantine, and rapid genome sequencing complemented by mass testing.

FUNDING:

Health and Medical Research Fund Commissioned Research on Control of Infectious Disease (see acknowledgments for full list).
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Topics: Variants Language: English Journal: Lancet Reg Health West Pac Year: 2021 Document Type: Article Affiliation country: J.lanwpc.2021.100281

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Topics: Variants Language: English Journal: Lancet Reg Health West Pac Year: 2021 Document Type: Article Affiliation country: J.lanwpc.2021.100281